Cimas MEDLABS, Zimbabwe’s top diagnostic and medical lab provider, has launched a major overhaul project across its labs.
Recognized as a Health Institution by the Medical Laboratory and Clinical Scientists Association of Zimbabwe, Cimas MEDLABS offers a wide array of pathology tests like haematology, biochemistry, histology, microbiology, viral load, and bone marrow aspirate to both Cimas members and non-members. Referrals mainly come from primary healthcare clinics and private physicians.
During a recent media briefing coinciding with Medical Laboratory Professionals Week (Lab Week) 2024, Dr. Tsitsi Moyo, Cimas Group Medical Advisor and Diagnostics Head, introduced this initiative. Dr. Moyo stressed that this project would notably cut down on referrals to Harare’s Central Laboratory, streamlining operations for efficiency gains.
“Cimas MEDLABS was established in 1985 and has grown from a single laboratory to eight locations country wide that incorporate a network of branches, satellite laboratories and collection points accounting for a significant volume of all pathology tests carried out in Zimbabwe,” Dr. Moyo said.

“As we commemorate the Lab Week, we are happy to be also celebrating our milestone of acquiring a state-of-the-art gene sequencer to be unveiled soon. With this of the gene sequencing addition, research will be a major thrust of Cimas. MEDLABS for the future in ensuring that the African genome is included in all aspects of health care, from diagnostics to pharmaceuticals and every aspect of science.”
For comments, Feedback and Opinions do get in touch with our editor on WhatsApp: +44 7949 297606.
